Sino Biological

Sino Biological

Sino Biological is a specialist provider of protein, antibody and gene products. Learn more

Launch date
Employees
Market cap
AUD1.5b
Enterprise valuation
AUD640m (Public information from Sep 2024)
Beijing China (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
CNY2020202120222023202420252026
Revenues1.6b965m575m646m626m736m878m
% growth783 %(40 %)(40 %)12 %(3 %)18 %19 %
EBITDA1.4b889m392m381m248m312m386m
% EBITDA margin88 %92 %68 %59 %40 %42 %44 %
Profit1.1b720m303m260m162m208m264m
% profit margin71 %75 %53 %40 %26 %28 %30 %
EV / revenue-24.4x22.4x16.5x11.2x9.6x8.0x
EV / EBITDA-26.4x32.8x27.9x28.4x22.5x18.2x
R&D budget26.1m40.1m60.1m87.4m---
R&D % of revenue2 %4 %10 %14 %---
  • Edit
DateInvestorsAmountRound

CNY200m

Series A

CNY100m

Early VC
N/A

CNY5.0b

IPO
Total FundingAUD63.8m

Recent News about Sino Biological

Edit
More about Sino Biologicalinfo icon
Edit

Sino Biological Inc. is a biotechnology company specializing in the production and supply of high-quality recombinant proteins, antibodies, and related services for life science research and drug development. The company serves a diverse range of clients, including academic institutions, pharmaceutical companies, and biotech firms, operating in the global biotechnology and pharmaceutical markets. Sino Biological's business model revolves around the development, production, and commercialization of its extensive catalog of biological products, which includes over 6,000 proteins and antibodies. The company generates revenue through the sale of these products and by offering custom services such as protein expression, antibody production, and assay development. Sino Biological has received support from notable organizations, including the Bill & Melinda Gates Foundation, for its contributions to COVID-19 diagnostics and research. The company's innovative solutions and high-quality standards have made it a trusted partner in the scientific community.

Keywords: recombinant proteins, antibodies, life science research, drug development, biotechnology, pharmaceutical, protein expression, antibody production, assay development, COVID-19 diagnostics.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Sino Biological

Edit